✦ LIBER ✦

Cyclsosporin-induced endothelial dysfunction: is tetrahydrobiopterin the solution?

✍ Scribed by I El-Hamamsy; M Grant; L.M Stevens; O Malo; L.P Perrault

Book ID: 117710216
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 48 KB
Volume: 22
Category: Article
ISSN: 1557-3117
DOI: 10.1016/s1053-2498(02)00751-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cyclosporine-Induced Coronary Endothelia

Cyclosporine-Induced Coronary Endothelial Dysfunction: Is Tetrahydrobiopterin the Solution?

✍ I. El-Hamamsy; M. Grant; L.M. Stevens; O. Malo; M. Carrier; L.P. Perrault 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 245 KB

Tetrahydrobiopterin attenuates homocyste

Tetrahydrobiopterin attenuates homocysteine induced endothelial dysfunction

✍ Bikramjit Dhillon; Mitesh V. Badiwala; Andrew Maitland; Vivek Rao; Shu-Hong Li; 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 98 KB

Cyclosporin induced endothelial dysfunct

Cyclosporin induced endothelial dysfunction: effects of the nitric oxide cofactor, tetrahydrobiopterin

✍ S Miriuka; V Rao; R.D Weisel; S.-H Li; T.J Anderson; A Maitland; P.W.M Fedak; R 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Folic acid reverses endothelial dysfunct

Folic acid reverses endothelial dysfunction induced by inhibition of tetrahydrobiopterin biosynthesis

✍ Stuart J. Moat; Zoe L. Clarke; Anil K. Madhavan; Malcolm J. Lewis; Derek Lang 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 402 KB

Tetrahydrobiopterin prevents cyclosporin

Tetrahydrobiopterin prevents cyclosporine induced vasomotor dysfunction of the rat thoracic aorta

✍ D Ramzy; L.C Tumiati; S Miriuka; D Delgado; H.J Ross; V Rao 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 67 KB

The eNOS cofactor tetrahydrobiopterin im

The eNOS cofactor tetrahydrobiopterin improves endothelial dysfunction in livers of rats with CCl4 cirrhosis

✍ Vasilica Matei; Aina Rodríguez-Vilarrupla; Ramon Deulofeu; Dolors Colomer; Merce 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 380 KB 👁 1 views

In cirrhosis, intrahepatic endothelial dysfunction is one of the mechanisms involved in the increased resistance to portal blood flow and therefore in the development of portal hypertension. Endothelial nitric oxide synthase (eNOS) uncoupling due to deficiency of tetrahydrobiopterin (BH4) results in